145 related articles for article (PubMed ID: 17266945)
1. Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction.
Monden Y; Kubota T; Tsutsumi T; Inoue T; Kawano S; Kawamura N; Ide T; Egashira K; Tsutsui H; Sunagawa K
Cardiovasc Res; 2007 Mar; 73(4):794-805. PubMed ID: 17266945
[TBL] [Abstract][Full Text] [Related]
2. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
Gurantz D; Yndestad A; Halvorsen B; Lunde OV; Omens JH; Ueland T; Aukrust P; Moore CD; Kjekshus J; Greenberg BH
Cardiovasc Res; 2005 Jul; 67(1):106-15. PubMed ID: 15949474
[TBL] [Abstract][Full Text] [Related]
3. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.
Fang L; Gao XM; Samuel CS; Su Y; Lim YL; Dart AM; Du XJ
Clin Sci (Lond); 2008 Aug; 115(3):99-106. PubMed ID: 18248324
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect.
Huang CX; Yuan MJ; Huang H; Wu G; Liu Y; Yu SB; Li HT; Wang T
Peptides; 2009 Dec; 30(12):2286-91. PubMed ID: 19747956
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and postinfarct remodeling: overexpression of IkappaB prevents ventricular dilation via increasing TIMP levels.
Trescher K; Bernecker O; Fellner B; Gyöngyösi M; Schäfer R; Aharinejad S; DeMartin R; Wolner E; Podesser BK
Cardiovasc Res; 2006 Feb; 69(3):746-54. PubMed ID: 16388787
[TBL] [Abstract][Full Text] [Related]
8. [Induction of left ventricular remodeling and dysfunction in the recipient heart following donor heart myocardial infarction: new insights into the pathological role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation model].
Nakamura H; Takata S; Umemoto S; Matsuzaki M
J Cardiol; 2003 Jan; 41(1):41-2. PubMed ID: 12564114
[TBL] [Abstract][Full Text] [Related]
9. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H
Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380
[TBL] [Abstract][Full Text] [Related]
10. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
11. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
12. Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure.
Berry MF; Pirolli TJ; Jayasankar V; Morine KJ; Moise MA; Fisher O; Gardner TJ; Patterson PH; Woo YJ
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):866-75. PubMed ID: 15573071
[TBL] [Abstract][Full Text] [Related]
13. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
[TBL] [Abstract][Full Text] [Related]
14. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
15. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
16. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
18. Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
[TBL] [Abstract][Full Text] [Related]
19. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
20. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
